Table 4.
Effects of telemedicine-based interventions in persons with overweight.
| Author and Year | Sample CG/IG |
Control Group | Intervention Group | ||||
|---|---|---|---|---|---|---|---|
| Intervention Type | BW at Baseline (kg) | BW Loss over Time (kg) | |||||
| Lugones-Sánchez et al., 2020 [39] | 29/80 | Usual care | Telemedicine + telemonitoring + telecare |
89.70 (SD = 13.10) | 3 months −2.04 * (CI = −2.57–−1.50) |
- | - |
| Thomas et al., 2017 [40] | 60/64 | Usual care | Telemonitoring | 93.40 (SD = 14.00) | 3 months −2.70 * (CI = −3.50–−2.00) |
- | 12 months −2.1 * (CI = −3.30–−1.10) |
| Alencar et al., 2019 [41] | 72/81 | Usual care | Telemonitoring | 106.70 (SD = 25.50) | 3 months −7.30 (SD = 4.40) * |
- | - |
| Duncan et al., 2020 [42] | 36/45 | Usual care | Telemonitoring | 90.80 (SD = 13.10) | - | 6 months −3.51 (SD = 4.77) |
12 months −3.59 (SD = 5.60) |
| Lugones-Sánchez et al., 2022 [43] | 120/120 | Usual care | Telemedicine | 91.40 (SD = 14.80) | 3 months −1.79 * (CI = −2.20–−1.37) |
- | 12 months −1.46 * (CI = −2.15–−0.77) |
| Thomas et al., 2019 [44] | 21/23 | Usual care | Telemedicine + telemonitoring + |
95.90 (SD = 17.00) | 6 months −7.2 (CI = −8.5–−5.9) |
12 months −6.6 (CI = −8.0–−5.1) |
18 months −5.5 (CI = −7.1–−3.9) |
| Johnson et al., 2019 [45] | 113/113 | Usual care | Telemonitoring + telecare |
112.80 (SD = 25.80) | 3 months −8.23 (SD = 4.50) * |
- | - |
CG = control group; IG = intervention group; BW = body weight; SD = standard deviation; CI = 95% confidence interval. * Statistically significant.